Two cases of "cannabis acute psychosis" following the administration of oral cannabis.

BACKGROUND: Cannabis is the most commonly used illegal drug and its therapeutic aspects have a growing interest. Short-term psychotic reactions have been described but not clearly with synthetic oral THC, especially in occasional users. CASE PRESENTATIONS: We report two cases of healthy subjects who were occasional but regular cannabis users without psychiatric history who developed transient psychotic symptoms (depersonalization, paranoid feelings and derealisation) following oral administration of cannabis. In contrast to most other case reports where circumstances and blood concentrations are unknown, the two cases reported here happened under experimental conditions with all subjects negative for cannabis, opiates, amphetamines, cocaine, benzodiazepines and alcohol, and therefore the ingested dose, the time-events of effects on behavior and performance as well as the cannabinoid blood levels were documented. CONCLUSION: While the oral route of administration achieves only limited blood concentrations, significant psychotic reactions may occur.

Reconstructing mid-to-recent Holocene paleoenvironments in the vicinity of ancient Amarynthos (Euboea, Greece).

This article examines the shoreline evolution and human occupation in the vicinity of the important archeological site of Amarynthos (Euboea Island, Greece) over the last six millennia. Archeological evidence indicates a continuous occupation of the site from the Bronze Age to the Roman period and the site is well-known, thanks to the existence of a sanctuary dedicated to the goddess Artemis. Based on the study of four boreholes, a paleogeographic reconstruction of the coastal landscape is proposed. Facies were determined based on mollusc identification, and sedimentology based on grain-size measurements (hand sieving for the fraction above 2 mm and LASER technique for particles below 2 mm) and loss-on-ignition. In addition, a series of 12 AMS radiocarbon dates define a reliable chronostratigraphy. Results suggest the presence of a fully marine environment from the early Holocene to ca. 2600-2400 cal. BC, which developed into a brackish environment from ca. 2600-2400 cal. BC to ca. 750 cal. BC due to the deltaic progradation of the nearby stream (Sarandapotamos River). From ca. 750 cal. BC onward, coastal swamps prevailed in the study area. Human-environmental interaction is discussed and particular attention is paid to the paleolandscape configuration of Amarynthos.

RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study.

BACKGROUND: Although Temozolomide is effective against glioblastoma, the prognosis remains dismal and new regimens with synergistic activity are sought for. METHODS: In this phase-I/II trial, pegylated liposomal doxorubicin (Caelyx, PEG-Dox) and prolonged administration of Temozolomide in addition to radiotherapy was investigated in 63 patients with newly diagnosed glioblastoma. In phase-I, PEG-Dox was administered in a 3-by-3 dose-escalation regimen. In phase-II, 20 mg/m2 PEG-Dox was given once prior to radiotherapy and on days 1 and 15 of each 28-day cycle starting 4 weeks after radiotherapy. Temozolomide was given in a dose of 75 mg/m2 daily during radiotherapy (60 Gy) and 150-200 mg/m2 on days 1-5 of each 28-day cycle for 12 cycles or until disease progression. RESULTS: The toxicity of the combination of PEG-Dox, prolonged administration of Temozolomide, and radiotherapy was tolerable. The progression free survival after 12 months (PFS-12) was 30.2%, the median overall survival was 17.6 months in all patients including the ones from Phase-I. None of the endpoints differed significantly from the EORTC26981/NCIC-CE.3 data in a post-hoc statistical comparison. CONCLUSION: Together, the investigated combination is tolerable and feasible. Neither the addition of PEG-Dox nor the prolonged administration of Temozolomide resulted in a meaningful improvement of the patient's outcome as compared to the EORTC26981/NCIC-CE.3 data.

Stratigraphy, sedimentology and depositional environments of the Permian to uppermost Cretaceous Batain Group, eastern-Oman

Permian to Late Cretaceous allochthonous sedimentary and volcanic rocks exposed in the Batain area (eastern Oman Margin) have received comparably little attention in the past. They largely were considered as part of the Hamrat Duru Group (Hawasina Complex) of the northern Oman Mountains. Structural, kinematic and biostratigraphic results from our mapping campaign in the Batain area have now revealed, that emplacement of these units occurred in a WNW direction during latest Cretaceous/Early Paleogene time. This clearly contrasts with previous models that postulated a S-ward directed obduction in Campanian times such as recorded from the Hawasina Complex and Semail Ophiolite in the Oman Mountains. We herewith establish the `'Batain Group'' comprising all Permian to Late Cretaceous allochthonous units in the Batain Area. These are: 1.) the Permian Qarari Formation deposited in the toe of a slope setting; 2.) the Late Permian to late Liassic Al Jil Formation comprising periplatform detritus and very coarse breccias; 3.) the Scythian to Norian Matbat Formation formed by slope deposits; 4.) the Early Jurassic to early Oxfordian Guwayza Formation with high energy platform detritus; 5.) the Mid-Jurassic to earliest Cretaceous Ruwaydah Formation seamount; and 6.) the Oxfordian to Santonian Wahrah Formation, mainly radiolarites; and 7.) the Santonian to latest Maastrichtian Fayah Formation built by flysch-type sediments. These sedimentary and volcanic rocks represent deposits of the former ``Batain basin'' off eastern-Oman, destroyed by compressional tectonics at the Cretaceous/Paleogene transition. For tectono-stratigraphic reasons the Batain Group does not form part of the Hawasina Complex.

Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: is it feasible?

BACKGROUND: The increasing use of erythropoietins with long half-lives and the tendency to lengthen the administration interval to monthly injections call for raising awareness on the pharmacokinetics and risks of new erythropoietin stimulating agents (ESA). Their pharmacodynamic complexity and individual variability limit the possibility of attaining comprehensive clinical experience. In order to help physicians acquiring prescription abilities, we have built a prescription computer model to be used both as a simulator and education tool. METHODS: The pharmacokinetic computer model was developed using Visual Basic on Excel and tested with 3 different ESA half-lives (24, 48 and 138 hours) and 2 administration intervals (weekly vs. monthly). Two groups of 25 nephrologists were exposed to the six randomised combinations of half-life and administration interval. They were asked to achieve and maintain, as precisely as possible, the haemoglobin target of 11-12 g/dL in a simulated naïve patient. Each simulation was repeated twice, with or without randomly generated bleeding episodes. RESULTS: The simulation using an ESA with a half-life of 138 hours, administered monthly, compared to the other combinations of half-lives and administration intervals, showed an overshooting tendency (percentages of Hb values > 13 g/dL 15.8 ± 18.3 vs. 6.9 ± 12.2; P < 0.01), which was quickly corrected with experience. The prescription ability appeared to be optimal with a 24 hour half-life and weekly administration (ability score indexing values in the target 1.52 ± 0.70 vs. 1.24 ± 0.37; P < 0.05). The monthly prescription interval, as suggested in the literature, was accompanied by less therapeutic adjustments (4.9 ± 2.2 vs. 8.2 ± 4.9; P < 0.001); a direct correlation between haemoglobin variability and number of therapy modifications was found (P < 0.01). CONCLUSIONS: Computer-based simulations can be a useful tool for improving ESA prescription abilities among nephrologists by raising awareness about the pharmacokinetic characteristics of the various ESAs and recognizing the factors that influence haemoglobin variability.

Early mobilization out of bed after ischaemic stroke reduces severe complications but not cerebral blood flow: a randomized controlled pilot trial.

OBJECTIVE: To evaluate whether early mobilization after acute ischaemic stroke is better than delayed mobilization with regard to medical complications and if it is safe in relation to neurological function and cerebral blood flow. DESIGN: Randomized controlled pilot trial of early versus delayed mobilization out of bed with incidence of severe complications as the primary outcome. SETTING: Acute stroke unit in the neurology department of a University Hospital. PARTICIPANTS: Fifty patients after ischaemic stroke with a National Institutes of Health Stroke Scale (NIHSS) score >6 were recruited. INTERVENTION: All patients were treated with physiotherapy immediately after their admission. In the early protocol patients were mobilized out of bed after 52 hours, in the delayed protocol after seven days. RESULTS: Eight out of 50 randomized patients were excluded from the per-protocol analysis because of early transfer to other hospitals. There were 2 (8%) severe complications in the 25 early mobilization patients and 8 (47%) in the 17 delayed mobilization patients (P < 0.006). There were no differences in the total number of complications or in clinical outcome. In the 26 patients (62%) who underwent serial transcranial Doppler ultrasonography, no blood flow differences were found. CONCLUSION: We found an apparent reduction in severe complications and no increase in total complications with an early mobilization protocol after acute ischaemic stroke. No influence on neurological three-month outcomes or on cerebral blood flow was seen. These results justify larger trials comparing mobilization protocols with possibly even faster mobilization out of bed than explored here.

Distinct levels in Pom1 gradients limit Cdr2 activity and localization to time and position division.

Where and when cells divide are fundamental questions. In rod-shaped fission yeast cells, the DYRK-family kinase Pom1 is organized in concentration gradients from cell poles and controls cell division timing and positioning. Pom1 gradients restrict to mid-cell the SAD-like kinase Cdr2, which recruits Mid1/Anillin for medial division. Pom1 also delays mitotic commitment through Cdr2, which inhibits Wee1. Here, we describe quantitatively the distributions of cortical Pom1 and Cdr2. These reveal low profile overlap contrasting with previous whole-cell measurements and Cdr2 levels increase with cell elongation, raising the possibility that Pom1 regulates mitotic commitment by controlling Cdr2 medial levels. However, we show that distinct thresholds of Pom1 activity define the timing and positioning of division. Three conditions-a separation-of-function Pom1 allele, partial downregulation of Pom1 activity, and haploinsufficiency in diploid cells-yield cells that divide early, similar to pom1 deletion, but medially, like wild-type cells. In these cells, Cdr2 is localized correctly at mid-cell. Further, Cdr2 overexpression promotes precocious mitosis only in absence of Pom1. Thus, Pom1 inhibits Cdr2 for mitotic commitment independently of regulating its localization or cortical levels. Indeed, we show Pom1 restricts Cdr2 activity through phosphorylation of a C-terminal self-inhibitory tail. In summary, our results demonstrate that distinct levels in Pom1 gradients delineate a medial Cdr2 domain, for cell division placement, and control its activity, for mitotic commitment.

Radiolarian biochronology and Pacific origin of Jurassic-Cretaceous oceanic terranes in Costa Rica and Puerto Rico

AbstractAs demonstrated during several recent geological conferences, there is still a large debate concerning the origins of the Mesozoic oceanic remnants on the Caribbean Plate. The geodynamic models describing the Mesozoic history of the Caribbean realm can be divided into two main categories based on the origin of the Caribbean Plate: 1) An in situ origin between the Americas; 2) A Pacific origin and an eastward transport relative to the Americas. The study of the ribbon-bedded radiolarite is a key in determining the origins of associated Mesozoic oceanic terranes and may help to achieve a general agreement regarding the basic principles on the evolution of the Caribbean Plate. The Early Jurassic to early Late Cretaceous Bermeja Complex of Puerto Rico, witch contains serpentinized peridotite, altered basalt, amphibolite, and chert (Mariquita Chert Formation), and the contemporaneous Santa Rosa Accretionary Complex, which crops out in several half-windows along the south shores of the Santa Elena Peninsula in northwestern Costa Rica, are two of these little-known and crucial ophiolitic mélanges. The Manzanillo and Matambú fore-arc Terranes of the Nicoya Peninsula in the northwestern Costa Rica, which contain Late Cretaceous to Early Paleogene radiolarian-bearing siliceous mudstones and cherts associated with arc-derived mafic to intermediate volcaniclastics, bring important information on the history of the western active margin of the Caribbean Plate. A systematic radiolarian study of these three regions is presented herein in three different articles.The radiolarian biochronology of the Mariquita Chert Formation of the Bermeja Complex presented in this work indicate an early Middle Jurassic to early Late Cretaceous (late Bajocian-early Callovian to middle Albian-middle Cenomanian) age for the Mariquita Chert Formation. The illustrated assemblages contain 150 species, of which 3 are new (Pantanellium karinae, Loopus bermejaense, and L. boricus), and belonging to 59 genera. A review of the previous radiolarian published works on this formation and the results of this study suggest that the Bermeja Complex ranges in age from Middle Jurassic to early Late Cretaceous (late Aalenian to middle Cenomanian) and also reveal a possible feature of the complex, which is the youngling of radiolarian cherts from north to south, evoking a polarity of accretion. On the basis of a currently exhaustive inventory of the ribbonbedded radiolaritic facies on the Caribbean Plate, a re-examination of the distribution of Middle Jurassic sediments associated with oceanic crust from the Caribbean realm, and a paleoceanographical argumentation on the water currents, we come to the conclusion that the radiolarite and associated Mesozoic oceanic terranes of the Caribbean Plate are of Pacific origin. The previous argument for a Pacific origin of the Bermeja Complex presented by Montgomery et al. (1994a), based on their radiolarian age and their estimation of the oldest Proto-Caribbean oceanic crust, is nowadays seriously questionable, owing to the recent progresses in radiolarian biostratigraphy and new discoveries on the age of the first oceanic crust spreading between the Americas. Furthermore, we interpret the radiolarian Parvicingulidae-rich assemblages in the low-latitude Caribbean context as potential indicators of upwelling or land nutrients inputs, instead of indicators of paleolatitudes,as firstly stated by Pessagno and Blome (1986). Eventually, a discussion on the origin of the cherts of the Mariquita Formation illustrated by Middle Jurassic to middle Cretaceous geodynamic models of the Pacific and Caribbean realms bring up the possibility that the rocks of the Bermeja Complex are remnants of two different oceans.The Santa Rosa Accretionary Complex contains various oceanic assemblages of alkaline basalt, radiolarite and polymictic breccias. The radiolarian biochronology (19 illustrated assemblages, 232 species belonging to 63 genera) presented in this work indicate an Early Jurassic to early Late Cretaceous (early Pliensbachian to earliest Turonian) age for the sediments associated with oceanic basalts or recovered from blocks in breccias or megabreccias from the Santa Rosa Accretionary Complex. This study brings to light the Early Jurassic age of a sequence of ribbon-bedded radiolarite, which was previously thought to be of Cretaceous age, intruded by alkaline basalts sills. The presence of Early Jurassic large reworked blocks of radiolarite in a polymictic megabreccia, firstly reported by De Wever et al. (1985) is confirmed. Therefore, the alkaline basalt associated with these radiolarites could be of Jurassic age. In the Carrizal tectonic window, Middle Jurassic radiolarian chert blocks and Early Cretaceous brick-red ribbon-bedded radiolarites overlying pillow basalts are interpreted as fragments of a Middle Jurassic oceanic basement accreted to an Early Cretaceous oceanic plate, in an intra-oceanic subduction context. Whereas, knobby radiolarites and black shale at Playa Carrizal are indicative of a shallower middle Cretaceous paleoenvironment. Other younger oceanic remnants documented the rapid approach of the site of sedimentation to a subduction trench during the late Early Cretaceous (AlbianCenomanian), maybe early Late Cretaceous (Turonian).In total, 60 species belonging to 34 genera were present in relatively well-preserved radiolarian faunas from volcaniclastics and associated pelagic and hemipelagic rocks of the Matambú and Manzanillo terranes, ranging in age from Late Cretaceous to Early Paleogene (middle Turonian-Santonian to late Thanetian-Ypresian). This study shows that radiolarians can provide significant biostratigraphic control in the Nicoya Peninsula where very similar lithologies of different ages are present. Two radiolarian samples directly date the Berrugate Formation for the first time (middle Turonian-Santonian and Coniacian-Santonian). These ages allow to determine a volcanic arc activity on the western edge of the future Caribbean Plate at least since the Santonian that could have lasted through the middle Turonian-early Campanian interval by stratigraphic superposition. Moreover on the basis of these radiolarian ages, the Loma Chumico Formation of Albian age, and the Berrugate Formation of middle Turonian-early Maastrichtian age, can now be clearly differentiated. Two samples from the Sabana Grande Formation give a Coniacian-Santonian age and a Coniacian-Campanian age and indicate that there is a stratigraphic gap of ~10 million years between this formation and the underlying Albian Loma Chumico Formation.RésuméComme cela a pu se vérifier à plusieurs reprises lors de conférences géologiques récentes, le débat sur l'origine des terrains océaniques mésozoïques de la Plaque Caraïbes est toujours d'actualité. Les modèles géodynamiques décrivant l'histoire de la région caraïbes peuvent être classés en deux catégories basées sur l'origine de la Plaque Caraïbes : 1) Une origine in situ entre les Amériques ; 2) Une origine Pacifique et un transport vers l'est, par rapport aux Amériques. L'étude des radiolarites rubanées est capitale pour la détermination de l'origine des terrains océaniques allochtones du Mésozoïque et peut être utile pour parvenir à un compromis général concernant les principes basiques de l'évolution de la Plaque Caraïbes. Le complexe de Bermeja à Porto Rico qui est constitué de péridotites serpentinisées, de basaltes altérés, d'amphibolites et de cherts (Formation des Cherts de Mariquita), et le Complexe d'Accrétion de Santa Rosa qui affleure dans plusieurs demi-fenêtres tectoniques au sud de la Péninsule de Santa Elena au nord-ouest du Costa Rica sont deux de ces mélanges ophiolitiques peu décrits et déterminants. Les terrains de fore-arc de Manzanillo et de Matambu dans la Péninsule de Nicoya au nord-ouest du Costa Rica qui sont composés de calcaires siliceux et de cherts riches en radiolaires associés à du matériel volcanique d'arc mafique à intermédiaire, apportent d'importantes informations sur l'histoire de la marge active occidentale de la Plaque Caraïbe. Une étude systématique des radiolaires de ces trois régions est présentée dans ce travail sous forme de trois articles.La biochronologie des radiolaires de la Formation des Cherts de Mariquita du Complexe d'Accrétion de Santa Rosa présentée dans ce travail indique un âge Jurassique Moyen inférieur à Crétacé Supérieur inférieur (Bajocien supérieur-Callovien inférieur à Albien moyen-Cénomanien moyen) pour la Formation des Cherts de Mariquita. Les assemblages illustrés contiennent 150 espèces, parmis lesquelles 3 sont nouvelles (Pantanellium karinae, Loopus bermejaense et L. boricus), et appartenant à 59 genres différents. Une révision des travaux publiés précédemment sur les radiolaires de cette formation, ainsi que les résultats de cette étude suggèrent que le Complexe de Bermeja a un âge allant du Jurassique moyen au Crétacé Supérieur inférieur (Aalénien supérieur à Cénomanien moyen) et révèle aussi une caractéristique éventuelle du complexe qui est le rajeunissement des radiolarites du nord au sud, évoquant une polarité d'accrétion. Sur la base d'un inventaire actuellement exhaustif du facies radiolaritique rubané sur la Plaque Caraïbes, d'un nouvel examen de la distribution globale des sédiments du Jurassique Moyen associés à de la croûte océanique et d'une argumentation paléocéanographique sur les courants, nous arrivons à la conclusion que les radiolarites et les unités tectoniques océaniques du Mésozoïque associées de la Plaque Caraïbes sont d'origine pacifique. L'argument antérieur pour une origine pacifique du Complexe de Bermeja présenté par Montgomery et al. (1994a), basé sur leur âge à radiolaire et leur estimation de l'âge de la plus vieille croûte océanique des Proto-Caraïbes, est sérieusement remis en question aujourd'hui, en raison des progrès récents de la biostratigraphie des radiolaires et des nouvelles découvertes concernant l'âge du début de l'océanisation entre les Amériques. En outre, dans le contexte de basses latitudes des Caraïbes, nous interprétons les assemblages à radiolaires riches en Parvicingulidae comme étant des indicateurs potentiels d'apports en nutriments des zones d'uppwelling ou des terres, plutôt que des indicateurs de paléolatitudes, comme exposer pour la première fois par Pessagno et Blome (1986). Finalement, une discussion sur l'origine des cherts de la Formation de Mariquita illustrée par des modèles géodynamiques du Jurassique Moyen au Crétacé moyen des régions pacifique et caraïbes, fait poindre la possibilité que les roches du Complexe de Bermeja proviennent de deux océans différents.Le Complexe d'Accrétion de Santa Rosa contient plusieurs assemblages océaniques différents de basaltes alcalins, radiolarites et brèches polymictes. La biochronologie des radiolaires (19 assemblages illustrés, 232 espèces appartenant à 63 genres) présentée dans ce second travail indique un âge Jurassique Inférieur à Crétacé Supérieur inférieur (Pliensbachien inférieur à Turonien initial) pour les sédiments associés aux basaltes océaniques ou provenant de blocs dans des brèches ou des mégabrèches du Complexe d'Accrétion de Santa Rosa. Cette étude met en évidence l'âge Jurassique Inférieur d'une séquence de radiolarites rubanées entrecoupée de sills de basaltes alcalins, dont l'âge estimé était précédemment le Crétacé.La présence de blocs plurimétriques de radiolarites d'âge Jurassique Inférieur remaniés dans une mégabrèche polymicte, dont la présence avait été signalée par De Wever et al. (1985), est confirmée. Par conséquent, les basaltes alcalins associés à ces radiolarites pourraient aussi être d'âge Jurassique. Dans la fenêtre tectonique de Carrizal, des blocs de radiolarites d'âge Jurassique Moyen et des radiolarites du Crétacé Inférieur recouvrant des basaltes en coussins sont interprétés comme des fragments d'une croûte océanique d'âge Jurassique Moyen accrétés à une plaque océanique d'âge Crétacé Inférieur, dans un contexte de subduction intra-océanique. Alors que dans la même zone, les radiolarites « noueuses » et les argiles noires associées sont interprétées comme des indicateurs d'un milieu peu profond au Crétacé. D'autres fragments océaniques plus jeunes documentent une approche rapide du lieu de sédimentation vers une fosse de subduction pendant le Crétacé Inférieur supérieur (Albien-Cénomanien), peut-être Crétacé Supérieur (Turonien).Au total, 60 espèces appartenant à 34 genres ont été déterminées à partir de faunes à radiolaires relativement bien préservées, extraites de roches volcanoclastiques et pélagiques à hémipélagiques associées, provenant des terrains de Matambu et Manzanillo et ayant des âges compris entre le Crétacé Supérieur et le Paléogène Inférieur (Turonien moyen-Santonien à Thanétien supérieur-Yprésien). Cette étude montre que les radiolaires peuvent fournir un contrôle stratigraphique significatif dans la Péninsule de Nicoya, où des lithologies similaires, mais d'âges différents sont présentes. Deux échantillons à radiolaires permettent de dater la Formation de Berrugate pour la première fois (Turonien moyen-Santonien et Coniacien-Santonien). Ces âges permettent d'établir une activité volcanique d'arc le long de la marge occidentale de la futur Plaque Caraïbes au moins depuis le Santonien et qui pourrait avoir durée jusqu'au Turonien moyen-Campanien inférieur. De plus, sur la base de ces âges à radiolaires, la Formation de Loma Chumico d'âge Albien, et la Formation de Berrugate d'âge Turonien moyen-Maastrichtien inférieur, peuvent maintenant être différenciées. Deux échantillons de la Formation de Sabana Grande donnent des âges Coniacien-Santonien et Coniacien-Campanien et indiquent qu'il existe une lacune stratigraphique d'environ 10 millions d'années entre cette formation et la Formation de Loma Chumico sous-jacente d'âge Albien.

Impact of etanercept-methotrexate therapy on patient-reported outcomes in rheumatoid arthritis patients with up to 12 months of symptoms.

Background/Purpose: Patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) are critical in evaluating RA treatment effects on function and health-related quality of life (HR-QoL). Significant improvement in PROs has been reported in RA studies of biologic agents, including etanercept (ETN), but most studies have been conducted in patients with established disease. In addition to assessing treatment effects in early RA, there is interest in therapeutic strategies that allow dose reduction or withdrawal of biologic therapy (biologic-free) after induction of response. The PRIZE trial is an ongoing, 3-period study to evaluate the efficacy of combined ETN and methotrexate (MTX) therapy in patients with early, moderate-to-severe RA and to assess whether efficacy (remission) can be maintained with ETN dose reduction or biologic-free (Period 2) or drug-free (Period 3). Herein we report PROs associated with ETN 50 mg QW plus MTX (ETN50/MTX) therapy administered for 52 wks in Period 1 (induction) of the PRIZE trial. Methods: In Period 1, MTX- and biologic-naı‥ve patients with early, active RA (symptom onset 12 mo from enrollment; DAS28 _3.2) received open-label ETN50/MTX for 52 wks. The starting dose of MTX was 10 mg QW; at the discretion of the investigator, titration was permitted up to a maximum of 25 mg QW to achieve remission. Corticosteroid boosts were administered to patients not achieving low disease state at wks 13 and 26, unless contraindicated or not tolerated. PROs were assessed using the Health Assessment Questionnaire (HAQ) total score; Patient Acceptable Symptom State (PASS); EuroQol-5 Dimensions (EQ-5D) total index; Short Form Health Survey (SF-36); Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue; Work Instability Scale for Rheumatoid Arthritis (RAWIS); and Work Productivity and Activity Impairment Questionnaire: Rheumatoid Arthritis (WPAI:RA). Results: A total of 306 patients received treatment in Period 1 (mITT population); 222 (73%) patients completed the period. The majority of patients were female (70%), with a mean age of 50 y, mean DAS28 of 6.0 (median, 6.0), and duration of disease symptoms from onset of 6.5 months (median, 6.3 mo). Significant and clinically meaningful improvements in PROs, including in HAQ, EQ-5D, SF-36, and FACIT-Fatigue, were demonstrated with ETN50/MTX therapy from baseline to the final on therapy visit (Table; P_0.0001). Similar improvements were observed in all dimensions of RA-WIS and WPAI:RA (Table; P_0.0001). Conclusion: Combination therapy with ETN50/MTX for 52 wks in patients with _12 mo of symptomatic, active RA resulted in significant, clinically important improvements in measures of physical function, including normal HAQ (66.6% of patients), HR-QoL, fatigue, and work productivity. These outcomes are consistent with those reported in prior studies in patients with more established disease.

Chemotherapy in patients with advanced pancreatic cancer: too close to death?

PURPOSE: We evaluated the attitude in using chemotherapy near the end of life in advanced pancreatic adenocarcinoma (PAC). Clinical and laboratory parameters recorded at last chemotherapy administration were analyzed, in order to identify risk factors for imminent death. METHODS: Retrospective analysis of patients who underwent at least one line of palliative chemotherapy was made. Data concerning chemotherapy (regimens, lines, and date of last administration) were collected. Clinical and laboratory factors recorded at last chemotherapy administration were: performance status, presence of ascites, hemoglobin, white blood cell (WBC), platelets, total bilirubin, albumin, LDH, C-reactive protein (C-rp), and Ca 19.9. RESULTS: We analyzed 231 patients: males/females, 53/47 %; metastatic/locally advanced disease, 80/20 %; and median age, 66 years (range 32-85). All patients died due to disease progression. Median overall survival was 6.1 months (95 % CI 5.1-7.2). At the last chemotherapy delivery, performance status was 0-1 in 37 % and 2 in 63 %. Fifty-nine percent of patients received one chemotherapy line, while 32, 8, and 1 % had second-, third-, and fourth line, respectively. The interval between last chemotherapy administration and death was <4 weeks in 24 %, ≥4-12 in 47 %, and >12 in 29 %. Median survival from last chemotherapy to death was 7.5 weeks (95 % CI 6.7-8.4). In a univariate analysis, ascites, elevated WBC, bilirubin, LDH, C-rp and Ca 19.9, and reduced albumin were found to predict shorter survival; however, none of them remained significant in a multivariate analysis. CONCLUSIONS: A significant proportion of patients with advanced PAC received chemotherapy within the last month of life. The clinical and laboratory parameters recorded at last chemotherapy delivery did not predict shorter survival.

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.

The present study evaluates the potential of third-generation lentivirus vectors with respect to their use as in vivo-administered T cell vaccines. We demonstrate that lentivector injection into the footpad of mice transduces DCs that appear in the draining lymph node and in the spleen. In addition, a lentivector vaccine bearing a T cell antigen induced very strong systemic antigen-specific cytotoxic T lymphocyte (CTL) responses in mice. Comparative vaccination performed in two different antigen models demonstrated that in vivo administration of lentivector was superior to transfer of transduced DCs or peptide/adjuvant vaccination in terms of both amplitude and longevity of the CTL response. Our data suggest that a decisive factor for efficient T cell priming by lentivector might be the targeting of DCs in situ and their subsequent migration to secondary lymphoid organs. The combination of performance, ease of application, and absence of pre-existing immunity in humans make lentivector-based vaccines an attractive candidate for cancer immunotherapy.

Measurement of β-tryptase in postmortem serum, pericardial fluid, urine and vitreous humor in the forensic setting.

In the realm of forensic pathology, β-tryptase measurement for diagnostic purposes is performed in postmortem serum obtained from femoral blood. This may be partially or completely unavailable in some specific cases, such as infant autopsies and severely damaged bodies. The aim of this study was to investigate the usefulness of determining β-tryptase levels for diagnostic purposes in alternative biological samples. Urine, vitreous humor and pericardial fluid were selected and measured in 94 subjects including: fatal anaphylaxis following contrast material administration (6 cases), hypothermia (10 cases), diabetic ketoacidosis (10 cases), gunshot suicide (10 cases), heroin injection-related deaths (18 cases), trauma (10 cases), sudden death with minimal coronary atherosclerosis (10 cases), severe coronary atherosclerosis without myocardial infarction (10 cases) and severe coronary atherosclerosis with myocardial infarction (10 cases). Postmortem serum and pericardial fluid β-tryptase levels higher than the clinical reference value (11.4ng/ml) were systematically identified in fatal anaphylaxis following contrast material administration and 6 cases unrelated to anaphylaxis. β-tryptase concentrations in urine and vitreous humor were lower than the clinical reference value in all cases included in this study. Determination of β-tryptase in pericardial fluid appears to be a possible alternative to postmortem serum in the early postmortem period when femoral blood cannot be collected during autopsy and biochemical investigations are required to objectify increased β-tryptase levels.